Join us again at the only FREE TO ATTEND (for drug developers & academics) industry-dedicated summit focused on advancing the best-in-class kinase inhibitor products with enhanced specificity, ...

While many farmers have already purchased fertiliser for this season, there will be some who haven’t been able to do that, whether it’s because of storage restrictions, cashflow or other reasons.

Australia's CSL has said its one-monthly treatment for hereditary angioedema has shown it is safe and effective in a phase 3 trial, and will be filed for approval in its current financial year which ...